A rare case of imatinib-induced erythroderma

Imatinib, a specific tyrosine kinase inhibitor is a newer anticancer agent, which has shown excellent efficacy in managing chronic myeloid leukemia. It is generally well tolerated with few side effects. Most commonly reported adverse events are maculopapular eruptions and periorbital edema. Severe a...

Full description

Saved in:
Bibliographic Details
Main Authors: Verma, Rajesh, Vasudevan, Biju, Pragasam, Vijendran, Neema, Shekhar
Format: Artigo
Language:Inglês
Published: Medknow Publications & Media Pvt Ltd 2013
Subjects:
Drug Watch
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3847261/
https://ncbi.nlm.nih.gov/pubmed/24347779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.121386
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items